Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
- Primary objective is to evaluate time to onset of effect of formoterol, 9 μg single
dose,compared with salmeterol, 50 μg single dose, in patients with moderate COPD.Forced
Expiratory Volume in 1 second (FEV1) measured by spirometry 5 minutes postdose.
- Secondary efficacy variables: Average FEV1 during the first 15 minutes (area under the
FEV1 curve from 0 to 15 minutes), Average FEV1 during 120 minutes (area under the FEV1
curve from 0 to 120 minutes)